Exploring the Applications of Pluripotent Stem Cells in Disease Modeling and Precision Medicine
Sarvananda L1* and Amal D Premarathna2
1Molecular Nutritional and Biochemistry Laboratory, University of Peradeniya, Sri Lanka
2School of Natural Sciences and Health, Tallinn University, Narva mnt 29, 10120 Tallinn, Estonia, Europe
Submission: February 17, 2023; Published: February 24, 2023
*Corresponding author:Sarvananda L, Molecular Nutritional and Biochemistry Laboratory, University of Peradeniya, Sri Lanka
How to cite this article:Sarvananda L* and Amal D Premarathna. Exploring the Applications of Pluripotent Stem Cells in Disease Modeling and Precision Medicine. J of Pharmacol & Clin Res. 2023; 9(2): 555757. DOI: 10.19080/JPCR.2023.09.555757
Keywords: Pluripotent stem cells; Neurodegenerative diseases; Sickle Cell Anemia; Cystic Fibrosis; Drug Therapies
Abbreviations: PSC: Pluripotent Stem Cells; ESC: Embryonic Stem Cells; IPSC: Induced Pluripotent Stem Cells
Editorial
Pluripotent stem cells (PSCs) are cells that can differentiate into any cell type in the body, and they have the potential to revolutionize genetic analysis and disease modeling. In this essay, I will discuss how PSCs can be used to model diseases and study their genetic basis. I will also examine the advantages and limitations of this approach, as well as the ethical considerations surrounding the use of PSCs.
Disease Modeling with Pluripotent Stem Cells
PSCs can be derived from a variety of sources, including embryos, adult tissues, and reprogrammed cells. These cells can then be differentiated into specific cell types, allowing researchers to create in vitro models of various diseases. For example, PSCs have been used to model neurodegenerative diseases such as Parkinson’s and Alzheimer’s, as well as genetic disorders such as cystic fibrosis and sickle cell anemia [1]. By creating disease-specific PSC lines, researchers can study the molecular and cellular mechanisms underlying the disease in question. This can include examining the effects of specific genetic mutations, as well as testing potential drug therapies. In some cases, PSCs can also be used to generate functional tissues or organs, allowing for more physiologically relevant disease models [2].
Genetic Analysis with Pluripotent Stem Cells
In addition to disease modeling, PSCs can also be used to study the genetic basis of disease. By creating PSC lines from individuals with specific genetic mutations, researchers can examine the effects of those mutations in a controlled setting.
This can help to identify the specific genes and pathways involved in disease development, as well as potential therapeutic targets [3]. PSCs can also be used to study the effects of epigenetic modifications on gene expression. For example, researchers can create PSC lines from individuals with epigenetic disorders such as Beckwith-Wiedemann syndrome, which is characterized by abnormal gene expression due to changes in DNA methylation patterns [4]. By studying these cells, researchers can gain a better understanding of how epigenetic modifications affect gene expression and potentially develop new treatments for epigenetic disorders.
Advantages and Limitations of PSC-based Disease Modeling and Genetic Analysis
One of the main advantages of PSC-based disease modeling and genetic analysis is the ability to create disease-specific cell lines. This allows researchers to study the effects of specific genetic mutations or environmental factors on disease development in a controlled setting. PSCs also have the potential to generate functional tissues and organs, allowing for more physiologically relevant disease models [2]. Another advantage of PSC-based research is the ability to generate large quantities of cells for analysis. This can be especially useful for drug discovery, as researchers can test potential therapies on a large number of cells in a relatively short amount of time. PSCs can also be used to generate cells for transplantation, potentially offering new treatments for a variety of diseases [5]. However, there are also several limitations to PSC-based research. One major limitation is the potential for genetic and epigenetic abnormalities in PSC lines. These abnormalities can affect the differentiation potential of PSCs and may lead to inconsistencies in disease modeling and genetic analysis [6]. Another limitation is the potential for immune rejection when using PSC-derived tissues for transplantation. While PSCs have the potential to generate functional tissues and organs, there is still a long way to go before these therapies become a reality. Researchers must overcome the challenge of immune rejection and ensure the safety of PSC-derived tissues before these therapies can be widely adopted [7].
Ethical Considerations
The use of PSCs raises several ethical considerations, particularly in the case of embryonic stem cells (ESCs). While ESCs have the greatest differentiation potential, their use has been controversial due to the fact that they are typically derived from discarded embryos from in vitro fertilization procedures. This has led to debates over the ethical implications of using embryos for research purposes. To address these concerns, researchers have developed alternative sources of PSCs, such as induced pluripotent stem cells (iPSCs), which are generated by reprogramming adult cells [8]. While iPSCs have some limitations compared to ESCs, they offer a more ethically acceptable source of PSCs for research purposes. In addition to the ethical considerations surrounding the use of PSCs, there are also concerns about the potential misuse of this technology. For example, PSCs could potentially be used for reproductive cloning or other unethical purposes. As such, there are calls for regulation and oversight of PSC research to ensure that it is conducted in an ethical and responsible manner [9].
Conclusion
Pluripotent stem cells have the potential to revolutionize genetic analysis and disease modeling, offering a powerful tool for understanding the molecular and cellular mechanisms underlying a variety of diseases. While there are limitations and ethical considerations surrounding the use of PSCs, researchers are continuing to explore the potential of this technology for both research and therapeutic applications.
- Editorial
- Editorial
- Disease Modeling with Pluripotent Stem Cells
- Genetic Analysis with Pluripotent Stem Cells
- Advantages and Limitations of PSC-based Disease Modeling and Genetic Analysis
- Ethical Considerations
- Conclusion
- References
References
- Raja WK, Fidanza A, Wang B (2020) Pluripotent stem cells in neurodegenerative and neuropsychiatric diseases. Mol Psychiatry 25(2): 282-298.
- Morizane A, Doi D, Kikuchi T (2013) Direct comparison of autologous and allogeneic transplantation of iPSC-derived neural cells in the brain of a nonhuman primate. Stem Cell Reports 1(4): 283-292.
- Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126(4): 663-676.
- Li X, Liu Y, Salz T, Hansen KD, Feinberg A (2016) Whole-genome analysis of the methylome and hydroxymethylome in normal and malignant lung and liver. Genome Res 26(12): 1730-1741.
- Huang Y, Tang L, Zhang W (2020) Stem cell-based therapies for liver diseases: state of the art and new perspectives. Cells 9(2): 262.
- Gore A, Li Z, Fung HL (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471(7336): 63-67.
- Lanza R, Atala A, Thomson JA (2013) Ethical issues in stem cell research and therapy. Stem Cell Rev 9(1): 1-4.
- Yamanaka S (2009) A fresh look at iPS cells. Cell 137(1): 13-17.
- Caulfield T, Murdoch C. Genetically modified stem cells: hope or hype? Nat Rev Gen.